Self-administered therapies in paroxysmal nocturnal hemoglobinuria: balancing quality of life with clinically relevant risks
Year: 2026
Type: article
Source: Expert Review of Hematology
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: paroxysmal nocturnal hemoglobinuria, self-administered therapy, complement inhibitors, pegcetacoplan, iptacopan, crovalimab, danicopan, extravascular hemolysis, breakthrough hemolysis, medication adherence, infection risk, pregnancy safety, patient-reported outcomes, quality of life, patient education
Open Access status: closed
OpenAlex ID: W7236242149
